Sabra Healthcare REIT, Inc. logo

Sabra Healthcare REIT, Inc. (SBRA)

Common Stock · Currency in USD · XNAS

Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.

Company Info

SIC6798
Composite FIGIBBG000MTDW24
CIK0001492298
IPONov 8, 2010
Sectorreal estate investment trusts

Highlights

Market Cap$5.01B
EPS$0.36
P/E Ratio55.60
Revenue$758.37M
Gross Profit$760.15M
Net Income$90.07M
Employees58
WSO252,145,717
Phone888-393-8248

Related Tickers

Analysis

Share Price Chart

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Sabra Healthcare REIT, Inc., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.

Returns By Period

Sabra Healthcare REIT, Inc. (SBRA) has returned 5.30% so far this year and 18.85% over the past 12 months. Looking at the last ten years, SBRA has achieved an annualized return of -0.03%, underperforming the Benchmark (SPY), which averaged 12.23% per year.

SBRA

1M-1.39%
6M9.48%
YTD5.30%
1Y18.85%
5Y1.95%
10Y-0.03%

Benchmark (SPY)

1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%

Monthly Returns

The table below presents the monthly returns of Sabra Healthcare REIT, Inc. (SBRA) with color gradation from worst to best to easily spot seasonal factors.

JanFebMarAprMayJunJulAugSepOctNovDec
2026-0.69%9.08%-6.42%3.28%
2025-3.35%0.54%5.81%1.77%-1.80%6.28%-2.33%4.20%-2.00%-3.73%10.29%-2.42%
2024-6.06%4.13%6.64%-6.07%4.89%5.77%5.87%4.67%9.21%3.36%-5.31%-7.28%
20236.89%-11.84%-2.95%-1.04%-1.05%3.79%10.37%-3.32%10.37%-1.87%7.04%-1.92%
2022-0.59%11.45%-21.56%18.48%-0.78%11.12%-3.42%-11.59%3.64%-5.63%-4.38%
2021-3.89%1.83%-1.31%4.01%-4.43%3.88%1.64%-14.16%-8.63%-5.10%-8.94%3.20%
20200.28%-9.53%-44.62%24.35%9.52%7.45%2.36%0.47%-6.29%-5.12%24.00%3.58%
201925.86%-12.17%6.86%-0.36%-1.63%1.65%4.19%3.49%5.76%7.14%-9.39%-4.09%
2018-3.42%-6.74%4.13%3.74%13.03%4.42%3.25%9.17%-1.87%-6.60%-11.31%-14.83%
20173.72%7.55%2.08%-2.58%-14.33%2.90%-4.33%-6.10%0.27%-9.45%-3.22%-2.80%
20165.93%-1.46%-2.94%15.34%6.61%-1.33%-7.13%-4.32%11.00%

Performance Indicators

The charts below present risk-adjusted performance metrics for Sabra Healthcare REIT, Inc. (SBRA) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.

Sharpe ratio

-2.00-1.000.001.002.003.00SBRA: 0.72SPY: 0.92

Sortino ratio

-6.00-4.00-2.000.002.004.00SBRA: 1.05SPY: 1.40

Omega ratio

0.501.001.502.00SBRA: 1.12SPY: 1.22

Calmar ratio

0.002.004.006.00SBRA: 0.96SPY: 1.20

Martin ratio

0.001.003.00SBRA: 0.22SPY: 0.42

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.

The chart below shows the rolling Sharpe ratio of SBRA compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Volatility Chart

The current Sabra Healthcare REIT, Inc. volatility is 1.28%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.

Income Statement

The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.

20252023202220212020201920182017201620152014201320122011
Liabilities And Equity (USD)5.49B5.39B5.75B5.97B5.99B6.07B6.67B7.03B2.27B2.49B2.06B1.20B916.88M749.65M
Equity Attributable To Parent (USD)2.82B2.80B3.06B3.38B3.41B3.49B3.25B3.43B1.02B1.05B941.87M460.16M305.49M326.57M
Equity Attributable To Noncontrolling Interest (USD)1.95M-----4.33M4.44M35.00K-106.00K-43.00K---
Equity (USD)2.82B2.80B3.06B3.38B3.41B3.49B3.25B3.44B1.02B1.05B941.82M460.16M305.49M326.57M
Long-term Debt (USD)2.53B2.41B2.51B2.39B2.37B2.40B3.23B3.39B1.21B1.40B1.09B688.08M569.82M-
Noncurrent Liabilities (USD)--------------
Current Liabilities (USD)2.67B2.58B2.69B2.59B2.58B2.58B3.41B3.60B1.25B1.43B1.12B737.67M611.39M423.08M
Liabilities (USD)2.67B2.58B2.69B2.59B2.58B2.58B3.41B3.60B1.25B1.43B1.12B737.67M611.39M423.08M
Noncurrent Assets (USD)--------------
Current Assets (USD)5.49B5.39B5.75B5.97B5.99B6.07B6.67B7.03B2.27B2.49B2.06B1.20B916.88M749.65M
Assets (USD)5.49B5.39B5.75B5.97B5.99B6.07B6.67B7.03B2.27B2.49B2.06B1.20B916.88M749.65M

News and Insights

Engineers Gate Trims Sabra Health Care REIT Stake as Investors Track Rental Income Trends

Engineers Gate Manager LP reduced its position in Sabra Health Care REIT by 1,513,777 shares (valued at ~$28.06 million), bringing the stake to 1.02% of the fund's assets. The sale reflects investor focus on healthcare REIT rental income sustainability, particularly as operators face challenges from Medicare/Medicaid reimbursement, labor costs, and occupancy trends.

The Motley Fool faviconThe Motley FoolEric Trie
Engineers Gate Builds $85 Million Position in Net-Lease Retail REIT Agree Realty

Engineers Gate Manager LP increased its stake in Agree Realty (ADC) by 1,144,617 shares, bringing its total position to $85.16 million. The investment represents 1.01% of the fund's assets under management. ADC shares have appreciated 13.4% over the past year, outperforming the S&P 500.

The Motley Fool faviconThe Motley FoolEric Trie
Sabra (SBRA) Q2 Revenue Jumps 7.4%

Sabra Health Care REIT exceeded Q2 2025 analyst expectations with strong performance in managed senior housing, reporting normalized FFO of $0.37 per share and revenue of $189.15 million, representing a 7.4% year-over-year increase.

The Motley Fool faviconThe Motley FoolJesterai
Compared to Estimates, Sabra (SBRA) Q1 Earnings: A Look at Key Metrics

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research faviconZacks Investment ResearchZacks Equity Research
Deere, ASML, Steel Dynamics And A Real Estate Stock: CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said if you are looking for a stock that’s on the verge of breaking out, Deere & Company (NYSE: DE). On March 25, Deere & Company said former Eastman Chemical Company executive, Kellye Walker, will join its leadership team as senior vice president, chief legal officer and worldwide public affairs, effective April 29. Stephen Weiss of Short Hills Capital Partners picked ASML Holding N.V. (NASDAQ: ASML), saying that ...

Benzinga faviconBenzingaAvi Kapoor
Sabra (SBRA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research faviconZacks Investment ResearchZacks Equity Research
Sabra Healthcare (SBRA) Lags Q4 FFO and Revenue Estimates

Sabra (SBRA) delivered FFO and revenue surprises of -2.94% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research faviconZacks Investment ResearchZacks Equity Research